Compare PCRX & HYMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | HYMC |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2010 | 2018 |
| Metric | PCRX | HYMC |
|---|---|---|
| Price | $36.48 | $15.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $33.57 | $24.50 |
| AVG Volume (30 Days) | 958.5K | ★ 2.1M |
| Earning Date | 11-09-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.44 | 64.26 |
| EPS | ★ 0.89 | N/A |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $3.84 | N/A |
| Revenue Next Year | $4.73 | N/A |
| P/E Ratio | $40.96 | ★ N/A |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $9.19 |
| 52 Week High | $36.67 | $58.73 |
| Indicator | PCRX | HYMC |
|---|---|---|
| Relative Strength Index (RSI) | 82.40 | 39.62 |
| Support Level | $22.00 | N/A |
| Resistance Level | $36.67 | $22.27 |
| Average True Range (ATR) | 0.04 | 1.44 |
| MACD | -0.37 | -0.03 |
| Stochastic Oscillator | 90.00 | 0.84 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Hycroft Mining Holding Corp is a United States-based gold and silver exploration-stage issuer. The company owns and is focused on developing its property, the Hycroft Mine, located northwest of Winnemucca, Nevada.